Filtered By:
Education: Academies
This page shows you your search results in order of relevance.
Order by Relevance | Date
Total 19305 results found since Jan 2013.
Effective Drug-Free Treatment For Migraine (Cefaly®)
The American scientific journal NEUROLOGY publishes the positive results of the PREMICE clinical study on the effectiveness and safety of the CEFALY(R) medical device in the prevention of migraine. NEUROLOGY (official journal of the American Academy of Neurology, the number one among the most-cited journals worldwide in the field of neurology) is publishing the results of the multi-centre PREMICE clinical study (PREvention of MIgraine with CEfaly(R)). The results show the effectiveness of Cefaly(R) in the reduction of migraines...
Source: Health News from Medical News Today - February 11, 2013 Category: Consumer Health News Tags: Headache / Migraine Source Type: news
Magnesium in Migraine Prophylaxis —Is There an Evidence‐Based Rationale? A Systematic Review
ConclusionThis systematic review provides Grade C (possibly effective) evidence for prevention of migraine with magnesium. Prophylactic treatment of migraine by means of high levels of magnesium dicitrate (600 mg) seems to be a safe and cost efficient strategy in clinical use.
Source: Headache: The Journal of Head and Face Pain - November 13, 2017 Category: Neurology Authors: Alexander von Luckner, Franz Riederer Tags: Review Article Source Type: research
Migraine With Aura Increases Women's Heart Attack Risk
Women who have migraine with aura may be at increased risk of heart attacks, and those taking newer contraceptives may be at higher risk of blood clots. These findings came from two new studies that will be presented at the 65th Annual Meeting of the American Academy of Neurology in San Diego, March 16 to 23, 2013. Visual disturbances and other sensory symptoms, such as flashing lights, numbness, tingling of the hands and face, blind spots, or smell distortion, that come before a migraine headache are known as migraine with aura...
Source: Health News from Medical News Today - January 16, 2013 Category: Consumer Health News Tags: Headache / Migraine Source Type: news
Migraine With Aura Linked To Heart Disease in Women
Women who have migraine with aura may be at increased risk of heart attacks, and those taking newer contraceptives may be at higher risk of blood clots. These findings came from two new studies that will be presented at the 65th Annual Meeting of the American Academy of Neurology in San Diego, March 16 to 23, 2013. Visual disturbances and other sensory symptoms, such as flashing lights, numbness, tingling of the hands and face, blind spots, or smell distortion, that come before a migraine headache are known as migraine with aura...
Source: Health News from Medical News Today - January 16, 2013 Category: Consumer Health News Tags: Headache / Migraine Source Type: news
Migraine Triggers Not As Powerful As We Think
Migraine with aura triggers may not be as powerful as most people think. The finding came from new research published in the journal Neurology, the medical journal of the American Academy of Neurology...
Source: Health News from Medical News Today - January 24, 2013 Category: Consumer Health News Tags: Headache / Migraine Source Type: news
Migraine Headache Prophylaxis.
Abstract
Migraines impose significant health and financial burdens. Approximately 38% of patients with episodic migraines would benefit from preventive therapy, but less than 13% take prophylactic medications. Preventive medication therapy reduces migraine frequency, severity, and headache-related distress. Preventive therapy may also improve quality of life and prevent the progression to chronic migraines. Some indications for preventive therapy include four or more headaches a month, eight or more headache days a month, debilitating headaches, and medication-overuse headaches. Identifying and managing environmen...
Source: American Family Physician - January 1, 2019 Category: Primary Care Authors: Ha H, Gonzalez A Tags: Am Fam Physician Source Type: research
New Trends in Migraine Pharmacology: Targeting Calcitonin Gene –Related Peptide (CGRP) With Monoclonal Antibodies
Conclusion
Migraine is a disabling and debilitating neurovascular painful condition representing more than 90% of cases of recurrent headache and toward which the tendency can be inherited (MacGregor, 2017). Divalproex sodium, sodium valproate, topiramate, metoprolol, propranolol, and timolol have proven strong, level A, evidence for migraine prevention (American Academy of Neurology and American Headache Society, 2015). However, all the classic oral preventative treatments including tricyclic antidepressants, beta blockers, 5-HT2 antagonists ergots and anti-epileptic drugs were not developed for migraine and provide 50% ...
Source: Frontiers in Pharmacology - April 8, 2019 Category: Drugs & Pharmacology Source Type: research
Does migraine affect income or income affect migraine?
(American Academy of Neurology) Studies show that migraine is more common among people with lower incomes. This relationship is examined in a study published in the August 28, 2013, online issue of Neurology®, the medical journal of the American Academy of Neurology, looking at whether developing migraines limits people's educational and career achievements, leading to a lower income status, or whether problems related to low income such as stressful life events and poor access to health care increase the likelihood of developing migraines.
Source: EurekAlert! - Social and Behavioral Science - August 28, 2013 Category: Global & Universal Source Type: news
Managing Migraine in the Times of COVID-19 Pandemic
Debashish Chowdhury, Debabrata DattaAnnals of Indian Academy of Neurology 2020 23(7):33-39COVID-19 pandemic is an emerging, rapidly evolving situation. Migraine is one of the commonest and highly disabling chronic neurological diseases in the world. During the pandemic and lockdown, migraine patients are facing an enormous problem in getting optimum care because of difficulty in access, forced social isolation, and encountering a health system that is getting rapidly overwhelmed. It is important that they must be protected by minimizing their visits to the clinics and emergency departments. Paradoxically multiple triggers ...
Source: Annals of Indian Academy of Neurology - April 23, 2020 Category: Neurology Authors: Debashish Chowdhury Debabrata Datta Source Type: research
Acute treatment of migraine in children and adolescents: review of the American Academy of Neurology Practice guideline update
Background Migraine is a brain disease that involves episodes of medium to severe headaches along with specific associated symptoms, including nausea, vomiting, photophobia and phonophobia, as defined by criteria developed by the International Headache Society. It is a common and disabling condition in children, estimated to affect ~10% of girls and ~6% of boys1 and it accounts for ~2% of visits to the emergency department in the USA.2 Migraines can disrupt life activities, such as participation in home, school and social functions, and can have a negative effect on quality of life. They can also be challenging to manage. ...
Source: Archives of Disease in Childhood - Education and Practice - November 18, 2021 Category: Pediatrics Authors: Cromb, D., Grigoratos, D. Tags: Guideline review Source Type: research
Introduction to Progressive Muscle Relaxation Therapy for Migraine in the Emergency Department: A Pilot Feasibility Study (P2.168)
Conclusions:Migraine patients presenting to the ED have severe and frequent migraines which make them candidates for preventive behavioral treatments. PMR is a behavioral technique which can be introduced in the ED setting. Follow-up studies should examine whether patients will continue to use these behavioral techniques at home.Study Supported by: Dr. Mia Minen is a recipient of the American Academy of Neurology-American Brain Foundation Practice Research Training Fellowship.Disclosure: Dr. Minen has nothing to disclose. Dr. Boubour has nothing to disclose. Dr. Powers has nothing to disclose. Dr. Grudzen has nothing to di...
Source: Neurology - April 17, 2017 Category: Neurology Authors: Minen, M., Boubour, A., Powers, S., Grudzen, C., Lipton, R. Tags: Headache: Clinical Trials and Therapeutics Source Type: research
Complementary and Integrative Medicine for Episodic Migraine: an Update of Evidence from the Last 3 Years
In conclusion, many complementary and integrative treatment options may be helpful for patients with migraines, and understanding potential efficacy, benefits, and risks can help providers discuss these modalities with their patients. Such a conversation can empower patients, build the therapeutic relationship, and increase self-efficacy, thus improving outcomes and patient-centered care.
Source: Current Pain and Headache Reports - February 21, 2019 Category: Neurology Source Type: research
Botulinum toxin: A lift for chronic migraines
This article briefly reviews treatments for migraine and introduces the role of onabotulinumtoxin A (Botox A) in improving the management of chronic migraines.
Source: Journal of the American Academy of Physician Assistants - May 27, 2016 Category: Primary Care Tags: Review Article Source Type: research
Magnesium in Migraine Prophylaxis-Is There an Evidence-Based Rationale? A Systematic Review.
CONCLUSION: This systematic review provides Grade C (possibly effective) evidence for prevention of migraine with magnesium. Prophylactic treatment of migraine by means of high levels of magnesium dicitrate (600 mg) seems to be a safe and cost efficient strategy in clinical use.
PMID: 29131326 [PubMed - as supplied by publisher]
Source: Headache - November 13, 2017 Category: Neurology Authors: von Luckner A, Riederer F Tags: Headache Source Type: research
4.45 prevalence and clinical correlates of migraines in a large sample of canadian adolescents with bipolar disorder
There is a well-documented association between bipolar disorder (BD) and migraine, with prevalence rates of 30.7 percent to 34.8 percent in adults with BD, much higher than the global rate of 11.6 percent. Within adults with BD, migraine has been associated with various demographic and clinical correlates, including female sex, bipolar II disorder (BD II) subtype, earlier BD onset, suicidality, comorbid anxiety, and less lithium treatment. Despite the robust literature regarding migraine in adults with BD, little is known about migraine in adolescents with BD.
Source: Journal of the American Academy of Child and Adolescent Psychiatry - September 30, 2019 Category: Psychiatry Authors: Ariel Silver, Sara Mehrhof, Lisa Fiksenbaum, Benjamin I. Goldstein Source Type: research
